Inhalation Sciences Sweden received a new order from prestigious returning client the Department of Pharmaceutical Technology and Bio pharmaceutics at the University of Vienna for the advanced in vitro cell exposure module XposeALI. The client previously purchased ISAB's aerosol generation platform Precise Inhale, in November 2020, plus two in vivo exposure modules. Precise Inhale and its suite of advanced exposure modules can generate voluminous high-precision data through all phases of preclinical research, from in vitro to in vivo, from even tiny amounts of test substance.

Now the Department is complementing its PreciseInhale suite with ISAB's advanced 3D cell exposure module XposeALI for a total order value of EUR 62,000. Unlike previous cell exposure systems - where cells are immersed in a liquid - XposeALI enables the study of the permeability of substances in an Air-Liquid Interface - a more physiological approach that mimics the conditions and processes occurring in the lungs.